Handbook of PAF and PAF Antagonists
Preview
Handbook of PAF and PAF Antagonists
ISBN |
Quantity:
Shopping Cart Summary
Book Description
Published in 1991: Since its characterization in the 1970s from antigen-stimulated rabbit basophils, platelet-activating factor (PAF) has been demonstrated to be produced by, and act upon, a variety of cell types. PAF antagonists, which have been obtained from both natural sources and chemical synthesis, now represent a new class of therapeutic agents and may provide new prospects for treating several major pathologies, particularly shock, ischemia and asthma. This book provides a unique overview of the chemistry, molecular modeling, pharmacology, and clinical potential of the major classes of natural and synthetic PAF antagonists. Compounds reviewed include the ginkgolides, diketopiperazines, neolignans, hetrazepines, cyclic and 1,3-dioxolan derived PAF analogs, pyrrolo[1,2-c]thiazoles, imidazo[2,1-a]isoquinolines and pyridoquinazoline carboxamides. Consisting of 12 chapters written by leading experts in PAF antagonist research, this book is essential reading for students, researchers, clinicians, and medical practitioners involved in this rapidly developing field of biomedical research.
Table of Contents
Part 1: Natural PAF Antagonists
1. Recent Progress in PAF Antagonist Research
Matyas Koltai
2. PAF Antagonists From Microbial Origin: Structure-Activity Relationship of Diketopiperazine Derivatives
Keiji Hemmi
3. Kadsurenone Type Neolignans, Potential PAF Antagonists: Chemistry and Distribution
Otto R. Gottlieb
Part 2: Synthetic PAF Antagonists
4. Structure Activity Relationships CV-3988 and CV-6209 PAF Antagonists Series
Muneo Takatani
5. Aminoacylates and Aminocarbamates of 2-Substituted 4-Hydroxymethyl 1,3-Dioxolans: Structure Activity Relationships and Biological Activity as PAF-Antagonists
Colette Broquet
6. GS 1065-180 and Related PAF Antagonists: Chemistry and Pharmacology
Gunnar Grue-Serensen
7. Structure Activity Relationships in Cyclic Analogs of PAF with PAF Antagonist Properties
William J. Houlihan
8. Pharmacology of Hetrazepines as PAF-Antagonists
Hubert O. Heuer
9. Structure-Activity Relationships in Pyrrolo [1,2-c] Thiazoles PAF Receptor
Daniel Lave
10. Structure Activity Relationships in 5-Aryl-2,3-Dihydroimidazo[2,la]Isoquinoline PAF Antagonists
William J. Houlihan
11. N-[w-(Heteroaryl)Alkyl]Carboxamide Derivatives as Platelet Activating Factor Antagonists: Structure-Activity Relationships and Biological Data
Jefferson W. Tilley
Part 3: Molecular Modeling
12. Structure Activities in PAF Acether Antagonist Series Using Molecular Lipophilic Potential Studies
J. P. Dubost
Editor(s)
Biography
Pierre Braquet Ph.D., D.Sc. is Director and General Manager of the Ipsen‐Beaufour pharmaceutical group at the Institut Henri Beaufour, Le Plessis Robinson, France and Professor at Louisiana State University, New Orleans, Louisiana.